Skip to main content
Log in

Recurrent tumefactive demyelination without evidence of multiple sclerosis or brain tumour

  • Letter to the Editors
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Lucchinetti CF, Gavrilova RH, Metz I et al (2008) Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain 131:1759–1775

    Article  CAS  PubMed  Google Scholar 

  2. Ng S, Butzkueven H, Kalnins R et al (2007) Prolonged interval between sentinel pseudotumoral demyelination and development of primary CNS lymphoma. J Clin Neurosci 14:1126–1129

    Article  PubMed  Google Scholar 

  3. Kim DS, Na DG, Kim KH et al (2009) Distinguishing tumefactive demyelinating lesions from glioma or central nervous system lymphoma: added value of unenhanced CT compared with conventional contrast-enhanced MR imaging. Radiology 251:467–475

    Article  PubMed  Google Scholar 

  4. Jain R, Ellika S, Lehmann NL et al (2010) Can permeability measurements add to blood volume measurements in differentiating tumefactive demyelinating lesions from high grade gliomas using perfusion CT? J Neurooncol 97:383–388

    Article  PubMed  Google Scholar 

  5. Kepes JJ (1993) Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients. Ann Neurol 33:18–27

    Article  CAS  PubMed  Google Scholar 

  6. Sloand EM, Rezvani K (2008) The role of the immune system in myelodysplasia: implications for therapy. Semin Hematol 45:39–48

    Article  CAS  PubMed  Google Scholar 

  7. Derweesh IH, Tannenbaum CS, Rayman PA et al (2003) Mechanisms of immune dysfunction in renal cell carcinoma. Cancer Treat Res 116:29–51

    CAS  PubMed  Google Scholar 

  8. Xia L, Lin S, Wang ZC et al (2009) Tumefactive demyelinating lesions: nine cases and a review of the literature. Neurosurg Rev 32:171–179

    Article  PubMed  Google Scholar 

  9. Nadkar MY, Deore RA, Singh R (2008) Tumefactive demyelination. J Assoc Physicians India 56:901–903

    CAS  PubMed  Google Scholar 

  10. Mao-Draayer Y, Braff S, Pendlebury W et al (2002) Treatment of steroid-unresponsive tumefactive demyelinating disease with plasma exchange. Neurology 59:1074–1077

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Häne.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Häne, A., Bargetzi, M., Hewer, E. et al. Recurrent tumefactive demyelination without evidence of multiple sclerosis or brain tumour. J Neurol 258, 318–320 (2011). https://doi.org/10.1007/s00415-010-5722-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-010-5722-1

Keywords

Navigation